Acute dietary nitrate supplementation reduces resting blood pressure in healthy normotensives. 26
Introduction 71
Acute and chronic dietary nitrate (NO 3 -) supplementation has been demonstrated to elicit dose-72 dependent reductions in resting blood pressure in normotensive and hypertensive populations in 73 prospective studies (e.g. 13, 21, 22, 25, 47) and meta-analyses (2, 44). These results highlight the 74 potential therapeutic benefit of targeting the nitrate-nitrite-nitric oxide pathway to increase the 75 bioavailability of the potent vasodilator, nitric oxide (NO) (27, 28, 47) . In contrast to 76 conventional NO synthesis through the oxidation of L-arginine by nitric oxide synthase (38), this 77 recently discovered pathway involves conversion of nitrate and nitrite back to bioactive NO 78 without the need for oxygen. Nitrate and nitrite derive from dietary nitrate ingestion and as 79 metabolic byproducts of NO oxidation (27, 28, 47) . Following consumption and absorption 80 through the gastrointestinal tract, ~25% of ingested dietary nitrate is taken up by the 81 enterosalivary circulation where it is reduced to nitrite by facultative anaerobic oral bacteria (27, 82 28, 47) . Swallowed nitrite can be spontaneously decomposed to produce NO and other bioactive 83 nitrogen oxides in the acidic environment of the stomach, however a large proportion is again 84 absorbed through the gastrointestinal tract, entering the circulation where it can be reduced to 85 NO by endogenous nitrite reductases (e.g. deoxyhemoglobin, deoxymyoglobin, molybdenum-86 containing enzymes) during physiological and pathological hypoxic conditions (27, 28, 47) . As a 87 result, nitrate and nitrite are now considered to represent important reservoirs for NO production 88 (1, 14) . 89
To date, the most common method of administering dietary nitrate has involved 90 supplementation with beetroot (BR) juice (2, 13, 32, 44) . In young normotensives, acute 91 ingestion of 250 ml (~5.5 mmol) of BR juice decreased resting systolic blood pressure (∆~5 92 mmHg) (22), while supplementation with 500 ml (~22.5 mmol) of BR juice was reported to 93 elicit larger reductions (∆~10/8 mmHg) (47). Importantly, the peak hypotensive responses in 94 both studies occurred ~3 hours following ingestion, aligned with the time course of peak plasma 95 nitrite concentration (22, 47). Similar findings have been reported following daily BR 96 supplementation for 4 weeks in hypertensives without evidence of tachyphylaxis (21). The 97 mechanisms responsible for these hypotensive effects have been attributed to the peripheral 98 vasodilatory actions of increased NO bioavailability (7, 47), as highlighted by an increase in 99 endothelium-dependent vasodilation (47). However, in addition to its role as a vasodilator, NO 100 exerts a tonic inhibitory influence on the central regulation of sympathetic outflow (41, 49). The 101 sympathetic nervous system is known similarly to impact blood pressure and endothelium-102 dependent vasodilation (18, 19), however, whether the beneficial effects of dietary nitrate 103 supplementation are mediated, at least in part, via a neural mechanism has not been studied. 104
Therefore, the purpose of the present investigation was to provide proof-of-concept that 105 acute dietary nitrate supplementation using BR can modulate central sympathetic outflow. We 106
hypothesized that compared to a nitrate-depleted BR placebo (PL), acute consumption of high-107
nitrate BR juice would reduce resting blood pressure and muscle sympathetic nerve activity 108 (MSNA). To determine whether changes in MSNA were mediated by peripheral or central 109 mechanisms we also examined spontaneous arterial sympathetic baroreflex sensitivity. 110
Additionally, as acute nitrate supplementation can improve human exercise performance (32), 111
we sought to determine whether the neural effects of BR were present during sympathoexcitation 112 elicited by static handgrip exercise. 
Participants 118
Twenty healthy men and women (10 men, 27 ± 11 years) were recruited to participate in 119 the study after providing informed written consent. All participants were normotensive, non-120 smoking, in sinus rhythm, free of known cardiovascular or metabolic disease, and not taking any 121 acute (<3 months) or chronic medications, including birth control or antibiotics. All participants 122 self-reported not currently or previously engaging in formal nitrate supplementation. Due to the 123 requirement of oral bacteria to convert dietary nitrate to nitrite (15, 47), participants were 124 required to abstain from using antibacterial mouthwash 30 days prior to the first visit and for the 125 duration of the study. Participants were reminded verbally throughout the study to ensure 126 compliance. All procedures were approved by the University of Guelph Research Ethics Board. explanations of the study requirements and protocols (e.g. microneurography), and attempted a 134 practice static handgrip contraction. After this, participants were randomized (1:1) to start (on a 135 subsequent visit) either BR or PL using a random sequence generator (Random.org) followed by 136 crossover after a >30 day washout. The 70 ml dose of high-nitrate BR (~6.4 mmol) juice is 137 considered to be equivalent to ~250 ml (~5.5-6.4 mmol) of regular BR juice (21, 22), while the 138 PL version is manufactured specifically for research purposes, as described (24), and is 139 indistinguishable in physical appearance and taste. The independent Human Nutraceutical 140
Research Unit at the University of Guelph maintained study blinding and controlled the 141 dispensing of BR and PL. The experimental protocol was completed during two identical study 142 visits conducted at the same time of day (±2 hours) and separated by at least one month. Diet 143 was not restricted during the course of the study, however, each participant was instructed to 144 refrain from making any major changes during the course of the study. Prior to each testing visit 145
participants were asked to abstain from caffeine, alcohol, and strenuous exercise for 24 hours. 146
During each testing visit participants entered the laboratory following voiding, underwent 147 anthropometric measurements, and were positioned supine on a comfortable bed for the 148 remainder of the study. Next, participants were asked to perform two handgrip contractions in 149 their left (non-dominant) hand to establish maximal volitional contraction (MVC) (Lafayette 150 Instrument, Lafayette, LA). Each contraction lasted ~3 seconds and was separated by 30 seconds 151 of rest and the highest value was taken as MVC. Participants then underwent instrumentation (~1 152 hour) and a 10 minute acclimatization period before continuous heart rate, blood pressure, 153 MSNA, as well as discrete minute-to-minute brachial blood pressure data were collected over a 154 10 minute baseline. Upon completion, participants consumed either BR or PL and remained in 155 the supine position for three hours. Continuous heart rate, blood pressure, and MSNA, along with 156 five discrete measurements of brachial blood pressure were sampled 165-180 minutes following 157 supplementation. This time period was chosen to align with peak hypotensive and plasma nitrite 158 responses reported previously (13, 22, 46, 47). Immediately following the three hour rest 159 protocol, participants underwent continuous measurements of heart rate, blood pressure, and 160 MSNA during a 3 minute resting baseline and 2 minute static handgrip contraction at 30% MVC. 161 162
Measurements 163
Electrocardiography (Lead II) was used to acquire beat-to-beat heart rate (ADInstruments 164 Pty Ltd, Australia). Respiratory movements were tracked to ensure spontaneous breathing 165 patterns using a piezoelectric transducer placed around the abdomen (Pneumotrace II, UFA, 166
Morro Bay, CA). To obtain accurate recordings of blood pressure, discrete left brachial blood 167 pressure was recorded using an automated sphygmomanometer (BPTru Medical Devices, 168
Coquitlam, Canada). Continuous beat-to-beat blood pressure was recorded from the right middle 169 finger using photoelectric plethysmography (Finometer MIDI, Finapres Inc, Netherlands). 170
Postganglionic multi-unit MSNA was measured from the right fibular nerve by 171 microneurography, as described previously (35, 40) . A low-impedance tungsten microelectrode 172 (2mΩ; Frederick Haer, Brunswick, ME) was inserted percutaneously into a motor fascicle and 173 adjusted until spontaneous multi-unit bursts of sympathetic activity were observed. Muscle 174 sympathetic activity was confirmed by reflexive increases in response to a breath hold and the 175 absence of responsiveness to unexpected clapping. The MSNA signal was amplified, band-pass 176 filtered (0.7-2.0 kHz), rectified, and integrated to obtain the mean voltage multi-unit neurogram 177 (Nerve Traffic Analyzer, Model 662C-4; Absolute Design and Manufacturing Services, Salon, 178 IA). The neural signal was monitored both audibly and visually to identify changes in the 179 recording site throughout the study protocol. 180
All continuous data was digitized and stored with LabChart (PowerLab, ADInstruments, 181
Colorado Springs, CO). Heart rate, respiration, blood pressure, and the integrated multi-unit 182 MSNA signal were recorded at a sampling frequency of 1000 Hz, while the raw MSNA signal 183 was collected at 10,000 Hz. 184 185
Data Analysis 186
All data was analyzed and tabled by investigators blinded to intervention allocation. 187
MSNA was analyzed using custom semi-automated LabView software (National Instruments, 188
Austin, Texas, USA) (35, 40). MSNA was quantified as burst frequency (bursts/min) and burst 189 incidence (bursts/100 heartbeats). Total MSNA was not calculated as a result of a singular site 190 change occurring during 13 of the 28 study visits (BR, n=5; PL, n=8). However, MSNA burst 191 occurrence exhibits excellent intra-day reproducibility within two or more time points on the 192 same day (16), justifying the use of MSNA burst frequency and incidence. Time-domain 193 calculation of spontaneous arterial sympathetic baroreflex sensitivity was completed by assessing 194 the relationship between diastolic blood pressure (input) and MSNA burst occurrence (output), 
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We recruited 20 participants between July 2015 and April 2016. Three participants were 222 excluded due to the inability to secure a MSNA recording site during visit 1 and three 223 participants withdrew from the study before completing visit 2. Complete high-quality 224 microneurographic recordings were obtained in fourteen participants, though only 11 participants 225 completed the static handgrip exercise protocol (3 dropouts due to time restrictions). Participant 226 characteristics are reported in Table 1 . Resting baseline heart rate, diastolic blood pressure, 227 MVC, and MSNA were consistent between BR and PL visits (All p>0.05), while systolic blood 228 pressure tended to be lower during the PL visit (p=0.04). The inter-test reliability was good-to-229 excellent (r > 0.6) for all resting baseline variables. 230
The changes in resting MSNA burst frequency (-3 ± 5 vs. 3 ± 4 bursts/min, p=0.001) and 231 burst incidence (-4 ± 7 vs. 4 ± 5 bursts/100 heartbeats, p=0.002) were lower following BR 232 compared to PL (Figure 1) . In contrast, the changes in resting systolic (-1 ± 5 vs. 2 ± 5 mmHg, 233 p=0.30) and diastolic (4 ± 5 vs. 5 ± 7 mmHg, p=0.68) blood pressure (Figure 1 ), heart rate (0 ± 4 234 vs. -1 ± 4 bpm, p=0.70), and spontaneous arterial sympathetic baroreflex sensitivity (0.2 ± 1.4 vs. 235 0.2 ± 1.3 bursts/100 heartbeats/mmHg, p=0.95) were not different between BR and PL. No 236 differences were detected (All p>0.05) for any of the parameters when measured during visit 1 or 237 visit 2 (i.e. no order effects). 238
During static handgrip exercise (Figure 2 ), the changes in systolic (11 ± 7 vs. 12 ± 8 239 mmHg, p=0.94) and diastolic (11 ± 4 vs. 11 ± 4 mmHg, p=0.60) blood pressure, heart rate (13 ± 240 10 vs. 12 ± 12 bpm; p=0.75), and MSNA burst frequency (6 ± 6 vs. 11 ± 10 bursts/min, p=0.12) 241
were similar following BR and PL. The change in MSNA burst incidence (1 ± 8 vs. 8 ± 9 242 bursts/100 heartbeats, p=0.04) was smaller following BR vs. PL. Secondary analyses without 243 adjusting for baseline as a covariate also found no differences during static handgrip in the Alternatively, increased NO may also influence sympathetic outflow by modulating peripheral 268 artery compliance and arterial baroreflex transduction (36, 48) . Given that the present study 269 observed a ~17% difference in post-BR and PL resting MSNA independent of a change in 270 spontaneous arterial sympathetic baroreflex sensitivity, our findings support a central 271 sympathoinhibitory action of dietary nitrate. Prior research has demonstrated that exogenous 272 nitrate or nitrite supplementation has the capacity to cross the blood-brain barrier and increase 273 NO bioavailability in the central nervous system (20, 42), providing a potential mechanism for 274 the observed reduction in MSNA. The capacity for BR to exert a central neural effect is 275 important as many of the benefits of dietary nitrate supplementation on blood pressure (2, 44), 276 endothelium-dependent vasodilation (47), and exercise capacity (32), may be caused similarly by 277 reductions in neurogenic vasoconstriction (18, 19, 39) . 278
Supporting the biological plausibility that BR can exert central sympathoinhibition, 279
analogous results (i.e. 12-30% reductions in MSNA burst incidence independent of changes in 280 sympathetic baroreflex sensitivity or blood pressure) have been reported in clinical patients 281 following lipophilic statin therapy (31, 34). A known pleiotropic benefit of statin therapy is the 282 upregulation of endothelial NO synthase and increase in endothelium-dependent vasodilation 283 (26). Work in animal models has established that the autonomic effects of statins are secondary 284
to NO-mediated reductions in oxidative stress in the rostral ventrolateral medulla (12), the 285 brainstem region considered the final central relay station to integrate sympathetic outflow which 286 provides the major excitatory input to sympathetic pre-ganglionic neurons (8). 287
During exercise, acute BR supplementation led to smaller MSNA burst incidence 288 responses during static handgrip than PL, while secondary analyses found significantly smaller 289 responses in both MSNA burst frequency and burst incidence. The latter results suggest that a 290 portion of the benefit BR supplementation has on sympathetic responses during exercise involves 291 modulation of resting baseline values. Given that BR has been shown to produce ergogenic 292 effects (32), lower MSNA could be the result of increased static handgrip time-to-failure. 293
However, an increase in handgrip endurance would be expected to elicit parallel responses in 294 blood pressure. Similar to our findings at rest, no differences in blood pressure responses were 295 found during static handgrip between BR and PL. In young healthy individuals MSNA does not 296 correlate with blood pressure at rest (19), and highlighting the complexity of integrative blood 297 pressure regulation, discordance in muscle sympathetic outflow and blood pressure responses 298 during static handgrip exercise have been reported previously in the literature (29, 37) . It is 299 important to remember that microneurographic assessments of sympathetic outflow reflect 300 central discharge, not the quantity of neurovascular transduction. It is also possible that reduced 301 MSNA occurred in parallel with increased sympathetic outflow to other tissues (e.g. renal) to 302 maintain systemic blood pressure responses. Nevertheless, reducing sympathetic vasoconstrictor 303 responses directed at skeletal muscle may permit greater blood flow during exercise and improve 304 exercise capacity (39). 305
The present results suggest a novel clinical application of dietary nitrate supplementation 306 as a therapeutic strategy to target sympathetic over-activation characteristic of most 307 cardiovascular disease states, including primary hypertension and heart failure (3, 9, 10, 35) . 308
Increased MSNA is known to be a significant predictor of mortality in patients with heart failure 309 We acknowledge several limitations in the present study. First, our study recruited a 318 convenience sample composed of young healthy participants for determining proof-of-concept. 319
Based on the knowledge that MSNA increases both with age (45) and many cardiovascular 320 disease states (3, 9, 10, 35), we would hypothesize that BR supplementation would elicit a 321 greater drop in sympathetic outflow in these populations. Second, prior batch analysis of the 322 confirm the difference between BR and PL but suggest that BR nitrate concentrations may be 326 lower than reported by the manufacturer. This discrepancy could have contributed to the lack of 327 change in resting blood pressure (in addition to low normotensive status of our participants), 328 though hypotensive responses are not universal across the literature, even at higher nitrate doses 329
(2, 44). Importantly, the present results suggest that the nitrate dose required to modulate blood 330 pressure and MSNA may not be equivalent. Finally, we did not determine plasma nitrite levels in 331 our study. The plateau in peak plasma nitrite (between 2-3 hours following consumption) has 332 been characterized in prior studies with consistent findings (13, 21, 22, 25), though inter-333 individual differences in peak nitrite concentration may contribute to between-participant 334 variability. Future studies are required to examine the dose-response relationships between 335 changes in plasma nitrite and MSNA. 336
In summary, acute supplementation with beetroot juice decreased resting MSNA and 337 attenuated muscle sympathetic activation during handgrip exercise. In concert with the findings 338 of unaltered arterial sympathetic baroreflex sensitivity, these results provide proof-of-concept 339 that dietary nitrate supplementation can cause central sympathoinhibition in a young healthy 340 population. Reductions in sympathetic outflow are likely to contribute to the cardiovascular 341 benefits of dietary nitrate supplementation, while offering a new autonomic restorative 342 intervention to be tested in future clinical trials in patient groups associated with sympathetic 343 over-activation (3, 9, 10, 35) . 551   552  553  554  555  556  557  558  559  560  561  562  563  564  565  566  567  568  569  570  571  572  573 
